Showing results (41-50 of 133) with videos related to
Sort By:
Pageof 14
International Journal of Colorectal Disease|July 13, 2011
A population-based analysis on the rate and surgical management of colorectal liver metastases in Southern GermanyChristina Hackl, Michael Gerken, Martin Loss, et al.Anticancer Research|January 30, 2022
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume CentreMiklos Acs, Laszlo Halmy, Sabina Isgandarova, et al.Maedica|May 4, 2017
An Invasive Treatment of Pseudomyxoma Peritonei with Intrathoracic InvolvementRami Ababneh, Pompiliu Piso, Hans-Stefan Hofmann, et al.Onkologie|December 17, 2008
[Treatment of gastric cancer]Florian Lordick, Karsten Ridwelski, Salah-Eddin Al-Batran, et al.World Journal of Gastrointestinal Oncology|January 23, 2016
Multimodality treatment strategies have changed prognosis of peritoneal metastasesCorneliu Lungoci, Aurel Ion Mironiuc, Valentin Muntean, et al.BMC Cancer|November 6, 2014
Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysisGabriel Glockzin, Michael Gerken, Sven A Lang, et al.Gastroenterology|October 31, 2002
Prognostic significance of calcium-binding protein S100A4 in colorectal cancerSilvia Gongoll, Gerrit Peters, Michael Mengel, et al.Surgical Innovation|July 12, 2013
Autofluorescent imaging in patients with peritoneal carcinomatosisPhilipp von Breitenbuch, Tonia Jeiter, Stephan Schreml, et al.Surgical Oncology|April 25, 2024
Anastomotic leakage following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A clinical cohort studyJonas Herzberg, Miklos Acs, Salman Yousuf Guraya, et al.Pleura and Peritoneum|September 4, 2023
Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Akash Kartik, Catharina Müller, Miklos Acs, et al.Pageof 14